A Guide to Covid, Flu and R.S.V. Vaccines This Fall
Major medical groups released new recommendations on who should get [...]
Major medical groups released new recommendations on who should get [...]
The new business unit is centered on four core capabilities, [...]
RNA-based vaccines and therapeutics may have faced a bumpy road [...]
Teva Pharmaceutical’s dreams of a first-in-class autoimmune blockbuster are being [...]
The SEC and the FDA have signed a three-year agreement [...]
TCR-T specialist TScan Therapeutics will reduce its workforce by 75% [...]
As part of the MFN drug pricing deal the Trump [...]
After losing Bristol Myers Squibb as a client, Cellares continues [...]
Novo Nordisk’s chief executive, Mike Doustdar, is a year into [...]
Novartis appears to have broken the curse of the BTK [...]